[ad_1]
US scientists have been able to develop a simple blood test that could be a better way to measure a child's risk of death in women with liver disease.
The results, published in the Lancet medical journal, will help doctors identify women with CPP and those at risk of contracting a pregnancy.
Yellow stasis is a liver disorder that results in the accumulation of bile acids in the blood. Pregnant women with symptoms of this disorder are more likely to give birth prematurely after about 37 weeks, to prevent the birth of dead fetuses.
The study found that the possibility of birth of dead embryos due to stagnation of the yellow juice in the liver is related to the concentration of bile acids in the blood of pregnant women, which can be determined by a simple blood test.
At present, more than 15% of women (at least 18,500 worldwide) suffer from bile acids of less than 100 μm per liter.
"This test represents a real advance in the diagnosis and management of liver disorders during pregnancy," said Dr. Carolyn Ovadia, a professor of liver disease at the University of Washington's School of Medicine. "The ability to measure risks for women and their children through simple tests Treatment on those who really need it."
"It also means that women will not have to unnecessarily offer premature labor, which carries risks for their children, including access to neonatal care units, respiratory problems and yellowing," he said. she said.
The researchers hope the results will help improve the pregnancy outcomes of high-risk women and allow thousands of pregnant women to rest safely.
Source link
